Zota Health Care LImited (NSE:ZOTA) — Market Cap & Net Worth
Market Cap & Net Worth: Zota Health Care LImited (ZOTA)
Zota Health Care LImited (NSE:ZOTA) has a market capitalization of $419.66 Million (Rs38.80 Billion) as of August 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #12947 globally and #658 in its home market, demonstrating a -1.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zota Health Care LImited's stock price Rs1279.30 by its total outstanding shares 30332655 (30.33 Million). See ZOTA capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Zota Health Care LImited Market Cap History: 2017 to 2026
Zota Health Care LImited's market capitalization history from 2017 to 2026. Data shows growth from $49.06 Million to $419.66 Million (34.10% CAGR).
Zota Health Care LImited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zota Health Care LImited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
Zota Health Care LImited's market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $49.06 Million | $715.80 Million | $55.41 Million | 0.07x | 0.89x |
| 2018 | $57.67 Million | $778.52 Million | $72.68 Million | 0.07x | 0.79x |
| 2019 | $60.04 Million | $852.33 Million | $55.48 Million | 0.07x | 1.08x |
| 2020 | $57.87 Million | $951.13 Million | $27.41 Million | 0.06x | 2.11x |
| 2021 | $128.54 Million | $1.07 Billion | -$2.09 Million | 0.12x | N/A |
| 2022 | $99.19 Million | $1.31 Billion | $89.08 Million | 0.08x | 1.11x |
| 2023 | $154.73 Million | $1.40 Billion | -$57.73 Million | 0.11x | N/A |
| 2024 | $262.79 Million | $1.80 Billion | -$143.48 Million | 0.15x | N/A |
| 2025 | $506.72 Million | $2.93 Billion | -$563.98 Million | 0.17x | N/A |
Competitor Companies of ZOTA by Market Capitalization
Companies near Zota Health Care LImited in the global market cap rankings as of August 4, 2026.
Key companies related to Zota Health Care LImited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Zota Health Care LImited Historical Marketcap From 2017 to 2026
Between 2017 and today, Zota Health Care LImited's market cap moved from $49.06 Million to $ 419.66 Million, with a yearly change of 34.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs419.66 Million | -17.18% |
| 2025 | Rs506.72 Million | +92.82% |
| 2024 | Rs262.79 Million | +69.83% |
| 2023 | Rs154.73 Million | +55.99% |
| 2022 | Rs99.19 Million | -22.83% |
| 2021 | Rs128.54 Million | +122.12% |
| 2020 | Rs57.87 Million | -3.62% |
| 2019 | Rs60.04 Million | +4.12% |
| 2018 | Rs57.67 Million | +17.54% |
| 2017 | Rs49.06 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Zota Health Care LImited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $419.66 Million USD |
| MoneyControl | $419.66 Million USD |
| MarketWatch | $419.66 Million USD |
| marketcap.company | $419.66 Million USD |
| Reuters | $419.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zota Health Care LImited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more